Case number: 7:19-bk-23648 - Purdue Pharma Inc. - New York Southern Bankruptcy Court

Case Information
  • Case title

    Purdue Pharma Inc.

  • Court

    New York Southern (nysbke)

  • Chapter

    11

  • Judge

    Sean H. Lane

  • Filed

    09/15/2019

  • Last Filing

    07/03/2022

  • Asset

    Yes

  • Vol

    v

Docket Header
CLMAGT, JtAdm, MEGA



U.S. Bankruptcy Court
Southern District of New York (White Plains)
Bankruptcy Petition #: 19-23648-shl

Assigned to: Judge Sean H. Lane
Chapter 11
Voluntary
Asset


Date filed:  09/15/2019

Debtor

Purdue Pharma Inc.

One Stamford Forum
201 Tresser Boulevard
Stamford, CT 06901
FAIRFIELD-CT
Tax ID / EIN: 06-1307486

represented by
Marshall Scott Huebner

Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
(212) 450-4099
Fax : (212) 450-3099
Email: marshall.huebner@davispolk.com

Eli J. Vonnegut

Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
212-450-4331
Email: eli.vonnegut@davispolk.com

U.S. Trustee

United States Trustee

Office of the United States Trustee - NY
Alexander Hamilton Custom House
One Bowling Green, Room 534
New York, NY 10004-1408
(212) 510-0500

 
 
Claims and Noticing Agent

Kroll Restructuring Administration LLC Claims Agent

(Formerly Prime Clerk LLC)
1 World Trade Center
31st Floor
www.kroll.com
New York, NY 10007
(212) 257-5450
 
 

Latest Dockets

Date Filed#Docket Text
07/03/202212Certificate of Mailing Re: Notice of Case Reassignment (related document(s) (Related Doc # 11)) . Notice Date 07/03/2022. (Admin.) (Entered: 07/04/2022)
07/01/202211Notice of Case Reassignment From Judge Robert D. Drain to Judge Sean H. Lane. (Gomez, Jessica). (Entered: 07/01/2022)
11/06/2019Pending Deadlines for Schedules Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities Terminated. (Vargas, Ana) (Entered: 11/06/2019)
11/06/20190Pending Deadlines for Schedules Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities Terminated. (Vargas, Ana) (Entered: 11/06/2019)
11/01/201910Statement of Financial Affairs - Non-Individual /Statement of Financial Affairs for Purdue Pharma Inc. Filed by Eli J. Vonnegut on behalf of Purdue Pharma Inc.. (Vonnegut, Eli) (Entered: 11/01/2019)
11/01/20199Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Schedules of Assets and Liabilities for Purdue Pharma Inc. Filed by Eli J. Vonnegut on behalf of Purdue Pharma Inc.. (Vonnegut, Eli) (Entered: 11/01/2019)
09/19/20198Order signed on 9/18/2019 Granting Motion Extending the Time to File Schedules of Assets and Liabilities, Schedules of Current Income and Expenditures, Schedules of Executory Contracts and Unexpired Leases and Statements of Financial Affairs (Related Doc # 3) . (Vargas, Ana) (Entered: 09/19/2019)
09/19/2019Deficiencies Set: Schedule A/B due 9/30/2019. Schedule D due 9/30/2019. Schedule E/F due 9/30/2019. Schedule G due 9/30/2019. Schedule H due 9/30/2019. Summary of Assets and Liabilities due 9/30/2019. Statement of Financial Affairs due 9/30/2019. Incomplete Filings due by 9/30/2019. (Vargas, Ana) (Entered: 09/19/2019)
09/19/2019Claims and Noticing Agent, Prime Clerk LLC, added to the case. (Vargas, Ana) (Entered: 09/19/2019)
09/19/2019JOINTLY ADMINISTERED CHAPTER 11 CASES UNDER 19-23649-rdd Purdue Pharma L.P. (LEAD CASE): 19-23650-rdd Purdue Transdermal Technologies L.P.;19-23651-rdd Purdue Pharma Manufacturing L.P.;19-23652-rdd Purdue Pharmaceuticals L.P.;19-23653-rdd Imbrium Therapeutics L.P.;19-23654-rdd Adlon Therapeutics L.P.;19-23655-rdd Greenfield BioVentures L.P.;19-23656-rdd Seven Seas Hill Corp.;19-23657-rdd Ophir Green Corp.;19-23658-rdd Purdue Pharma of Puerto Rico;19-23659-rdd Avrio Health L.P.;19-23660-rdd Purdue Pharmaceutical Products L.P.;19-23661-rdd Purdue Neuroscience Company;19-23662-rdd Nayatt Cove Lifescience Inc.;19-23663-rdd Button Land L.P.;19-23664-rdd Paul Land Inc.;19-23665-rdd Quidnick Land L.P.;19-23666-rdd Rhodes Associates L.P.;19-23667-rdd Rhodes Pharmaceuticals L.P.;19-23668-rdd Rhodes Technologies;19-23669-rdd UDF LP;19-23670-rdd SVC Pharma LP and19-23671-rdd SVC Pharma Inc.. (Vargas, Ana) (Entered: 09/19/2019)